Drug Lab Brass Face Investor Suit Over DOJ Primate Probe
Directors and officers of drug development partner Charles River Laboratories International Inc. face a shareholder derivative complaint over claims they harmed investors by not disclosing the legal risks the company faced from...To view the full article, register now.
Already a subscriber? Click here to view full article